BD & Licensing Lead, Antibody Therapeutics

HW3

San Francisco, Northern (CA, KY)

On-site

USD 180,000 - 260,000

Full time

8 days ago

Application generator

Turn this role into an interview — a resume and cover letter built around what this employer wants.

Get past ATS filters

Job summary

HW3 in San Francisco is seeking a Manager, Business Development & Licensing for Antibody Therapeutics. You will lead out-licensing, co-development, and strategic partnerships across immunology, oncology, neurology, and more, blending science with deal making.

You will drive strategy, prepare business cases, lead discussions, and coordinate due diligence with R&D, regulatory, and finance. The role requires a PhD and deep antibody discovery experience, plus Mandarin and English for global

Qualifications

PhD in pharmacology, immunology, cancer biology, or related biomedical discipline.
Strong background in antibody drug discovery, target validation and hit-to-lead optimization.
Ability to translate complex data into a compelling therapeutic and licensing narrative.
Familiarity with modern antibody modalities (monoclonal antibodies, bispecifics, ADCs).
Strategic mindset to align internal platforms with external partner needs.
Bilingual Mandarin and English required for global collaboration.

Responsibilities

Identify and advance external partnership opportunities, including out-licensing and co-development transactions.
Develop and present business cases with strategic rationale, assumptions, risks, and value drivers.
Lead external opportunity discussions with minimal supervision.
Drive cross-functional due diligence and alliance management with R&D, CMC, Clinical, Regulatory, Operations, and Finance.
Manage BD transaction processes including proposals, term sheets, negotiations, and post-deal alliance management.
Represent the organization at industry, investor, and partnering conferences and maintain senior-level external relationships.